Search the Newsreel

Microvast (MVST) Earnings Date and Reports 2026

ROSEN, NATIONAL INVESTOR COUNSEL, Encourages Microvast Holdings, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - MVST

The Rosen Law Firm is reminding Microvast Holdings, Inc. investors who purchased securities between April 1, 2025, and March 16, 2026, about the September 21, 2026, lead plaintiff deadline for a securities class action lawsuit. The lawsuit alleges that Microvast made materially false and …

Shree Vasu Logistics Board Clears Q1 Results, Auditor Reappointment and AGM Plan

Shree Vasu Logistics posts Q1 FY27 results, extends auditor term and backs associate with loan

Microvast Holdings Stock (MVST) Opinions on Upcoming Earnings Report

MVST Stock Slides Toward Biggest Drop In 3 Years On Q1 Shocker: CEO Calls Weak Quarter ‘Temporary’

LeMaitre Vascular, Inc. Just Missed Earnings - But Analysts Have Updated Their Models

LeMaitre Vascular, Inc. recently missed its statutory earnings estimates, causing its shares to drop by 21%. Despite the earnings miss, revenue remained in line with predictions, and analysts have largely maintained their price targets, though they slightly downgraded next year's EPS forecasts. The company …

MVST Deadline Alert: The Gross Law Firm Reminds Microvast

The Gross Law Firm is alerting investors of Microvast Holdings, Inc. (MVST) about a securities class action lawsuit with a lead plaintiff deadline of September 21, 2026. The lawsuit alleges that Microvast made false and misleading statements regarding its margin targets and its ability …

Univastu India consolidated net profit rises 281.61% in the June 2026 quarter

MVST CLASS ACTION NOTICE: Faruqi & Faruqi, LLP Reminds Microvast

Faruqi & Faruqi, LLP is reminding investors of Microvast Holdings, Inc. (NASDAQ: MVST) about a securities class action lawsuit deadline on September 21, 2026. The lawsuit alleges that Microvast made false and misleading statements regarding its margin targets, inventory management, commercial vehicle rollouts, and …

Form 8K Microvast Holdings Inc For: 7 August By Investing.com

This article from Investing.com reports on a Form 8K filing by Microvast Holdings Inc. for August 7. It includes a brief mention of the company's stock performance and contains various financial market data and news headlines.

Microvast Holdings appoints Derek Liu as chief accounting officer

Microvast Holdings, Inc. (NASDAQ:MVST) has appointed Derek Liu as its new chief accounting officer, effective on or about Friday. Mr. Liu, formerly CFO at Silvercorp Metals Inc., will receive an annual base salary of $350,000 plus bonus eligibility. This appointment comes as the battery …

31% Undervalued? LeMaitre Vascular (LMAT) After Earnings Guidance And Dividend Update

LeMaitre Vascular (LMAT) reported strong Q2 2026 results with increased sales and net income, affirming its quarterly dividend. While analysts view the stock as 31.4% undervalued with a fair value of $118.75 due to a strong product pipeline and pricing power, Simply Wall St's …

SueWallSt Reminds Microvast Holdings Investors of the Pending Class Action Lawsuit With a Lead Plaintiff Deadline of September 21, 2026 - MVST

SueWallSt is reminding investors of Microvast Holdings, Inc. (NASDAQ: MVST) about a pending securities class action lawsuit with a lead plaintiff deadline of September 21, 2026. The lawsuit alleges that Microvast made misleading statements concerning executive turnover and business representations, causing a 34.2% drop …

LeMaitre management to meet investors at virtual Aug. 11 event

LeMaitre Vascular, Inc. (Nasdaq: LMAT) announced that its management will participate in investor meetings at the 11th Annual Needham Virtual MedTech & Diagnostics 1x1 Conference on Tuesday, August 11, 2026. The event will be held in a virtual format. The company specializes in devices …

Microvast sets 5 p.m. ET webcast to discuss Q2 results

Microvast (NASDAQ: MVST) will release its second-quarter 2026 financial results after market close on Monday, August 10, 2026. Following the release, management will host a webcast and earnings conference call at 4:00 p.m. Central Time (5:00 p.m. Eastern Time) to discuss the results and …

AZEV4: Por que as ações da Azevedo & Travassos estão despencando hoje? - Investing.com Brasil

Pomerantz Law Firm Announces the Filing of a Class Action Against Microvast Holdings, Inc. and Certain Officers - MVST

Pomerantz LLP has filed a class action lawsuit against Microvast Holdings, Inc. (NASDAQ: MVST) and some of its officers. The lawsuit, filed in the U.S. District Court for the Southern District of Texas, Houston Division, alleges that Microvast made materially false and misleading statements …

LeMaitre Vascular To Go Ex-Dividend On August 20th, 2026 With 0.25 USD Dividend Per Share

LeMaitre Vascular is scheduled to go ex-dividend on August 20th, 2026. The company will be distributing a dividend of $0.25 per share to its shareholders. Investors wishing to receive this dividend should ensure they own shares before the ex-dividend date.

LeMaitre to Participate in the 11th Annual Needham Virtual MedTech & Diagnostics 1x1 Conference

LeMaitre Vascular, Inc. announced its participation in the 11th Annual Needham Virtual MedTech & Diagnostics 1x1 Conference on August 11, 2026, where management will hold investor meetings. The company, a provider of devices for peripheral vascular disease, aims to connect with investors regarding its …

DEADLINE ALERT for MVST, PRIM, and EQPT: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders

The Law Offices of Frank R. Cruz has issued a deadline alert for shareholders of Microvast Holdings, Inc. (MVST), Primoris Services Corporation (PRIM), and EquipmentShare.com Inc. (EQPT), reminding them of upcoming lead plaintiff deadlines on September 21, 2026. Class action lawsuits allege that these …

LeMaitre Vascular (LMAT) Hit by Profit Taking

Conestoga Capital Advisors, an asset management company, released its second-quarter 2026 investor letter. A copy of the letter can be downloaded here. The letter reports a positive market shift towards Small Caps, with the Russell 2000 Index achieving its best first half since 1991 …

LeMaitre Vascular (LMAT) Stock Price Hit By Revenue Guidance Cut

LeMaitre Vascular (NASDAQ:LMAT) Sets New 1-Year Low on Analyst Downgrade

LeMaitre Vascular (NASDAQ:LMAT) shares hit a new 52-week low after Wells Fargo downgraded its price target and maintained an equal-weight rating, amidst a broader shift in analyst sentiment to "Hold." The company's Q2 revenue and EPS, despite year-over-year growth, missed analyst expectations, leading to …

LeMaitre Vascular, Inc. Stock 12‑Month Price Target Cut to $116.25, Implies 10% Upside

LeMaitre Vascular, Inc.'s average 12-month price target has been lowered from $118.75 to $116.25 by 8 analysts, suggesting a 10% upside from its Aug. 4 closing price. The consensus rating remains a "Buy" from 9 analysts, with 5 recommending Buy and 4 recommending Hold.

LeMaitre Vascular stock hits 52-week low at 79.38 USD

LeMaitre Vascular (LMAT) stock recently hit a 52-week low at $79.38, despite having a strong 1-year return of nearly 25% and being up over 31% year-to-date. The medical device maker is trading below its Fair Value estimate, with analysts setting price targets between $100 …

LeMaitre Vascular Down Over 22%, On Track for Largest Percent Decrease Since October 2008 -- Data Talk

LeMaitre Vascular Inc. (LMAT) experienced a significant drop of over 22%, trading at $82.06, which would mark its lowest close since January 2026. This decline puts the company on track for its largest percentage decrease since October 2008. The stock is down 30.1% from …

LeMaitre Vascular (NASDAQ:LMAT) Price Target Cut to $94.00 by Analysts at Wells Fargo & Company

Wells Fargo & Company analysts have cut their price target for LeMaitre Vascular (NASDAQ:LMAT) to $94.00 from $104.00, maintaining an "equal weight" rating. This adjustment follows the company's recent earnings report where Q2 EPS of $0.74 missed the consensus estimate of $0.81, and revenue …

MVST Shareholder Alert: Investors With Losses May Seek to Lead the Class Action in Microvast Holdings Securities Lawsuit - Contact Levi & Korsinsky

Levi & Korsinsky, LLP has filed a class action lawsuit against Microvast Holdings, Inc. (NASDAQ: MVST) on behalf of investors who purchased securities between April 1, 2025, and March 16, 2026, and suffered losses. The lawsuit alleges that Microvast's senior officers made materially false …

LeMaitre Vascular, Inc. (NASDAQ:LMAT) Announces $0.25 Quarterly Dividend

LeMaitre Vascular, Inc. (NASDAQ:LMAT) declared a quarterly dividend of $0.25 per share, payable on September 3rd to shareholders of record on August 20th. This announcement comes despite the company missing analyst expectations for both Q2 revenue and EPS, and subsequently lowering its full-year 2026 …

LeMaitre Vascular (NASDAQ:LMAT) Stock Rating Lowered by Barrington Research

Royal Bank of Canada Sells 18,448 Shares of LeMaitre Vascular, Inc. $LMAT

Royal Bank of Canada reduced its stake in LeMaitre Vascular, Inc. (LMAT) by 6.3% in the first quarter, selling 18,448 shares but still retaining a significant holding of 272,654 shares valued at $29.8 million. This comes as LeMaitre Vascular reported Q2 earnings that missed …

Kaplan Fox Shareholder Alert: Deadline to Lead in the Securities Fraud Lawsuit Against Microvast Holdings, Inc. (NASDAQ: MVST) is September 21, 2026

Kaplan Fox & Kilsheimer LLP has filed a class action lawsuit against Microvast Holdings, Inc. (NASDAQ: MVST) on behalf of investors who purchased securities between April 1, 2025, and March 16, 2026. The lawsuit alleges that Microvast made false and misleading statements regarding its …

LeMaitre Vascular Inc (LMAT) (Q2 2026) Earnings Call Highlights: Strong EPS Growth and ...

LeMaitre Vascular (LMAT) Q2 Earnings and Revenues Lag Estimates

LeMaitre Vascular (LMAT) reported Q2 earnings of $0.74 per share, falling short of the Zacks Consensus Estimate of $0.81, though it was an increase from $0.60 a year ago. The company's revenues of $70.38 million also missed expectations, despite being higher than the $64.23 …

LeMaitre Vascular (NASDAQ:LMAT) Issues Q3 2026 Earnings Guidance

LeMaitre Vascular (NASDAQ:LMAT) has lowered its third-quarter 2026 earnings guidance, projecting EPS of $0.660–$0.710 and revenue of $66.3–$68.3 million, both below analyst consensus. The company also updated its full-year 2026 EPS guidance to $2.840–$2.940. Despite the lowered outlook, analyst sentiment remains "Moderate Buy" with …